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ABSTRACT By using both a 3 to 4 ms quenched-86Rb+ flux assay and native acetylcholine receptor (AChR) rich
electroplaque vesicles on which 50-60% of acetylcholine activation sites were blocked with a-BTX, we determined
apparent rates of agonist-induced inactivation in AChR fromTorpedo under conditions where measured flux response
was directly proportional to initial 86Rb+ influx rate. Inactivation kinetics with acetylcholine in both the activating range
(10 uM-10 mM) and the self-inhibiting range (15-100 mM) were measured at 40C. In the presence of 10 ,M-l mM
acetylcholine, inactivation is characterized by a single exponential rate constant, kd (fast desensitization). Plots of kd vs.
acetylcholine concentration display maximum kds [kd(max)] of 6.6-8.0 s-', half-maximal kd at 102 ± 16MM, and a Hill
coefficient of 1.6 ± 0.3, closely paralleling the initial ion flux response of AChR. Thus, fast desensitization probably
occurs from a doubly-liganded preopen state or the open channel state. In the self-inhibiting acetylcholine concentration
range, inactivation is biphasic. A "rapid inactivation" phase is complete within 30 ms, followed by fast desensitization at
a rate close to kd(max). Both the rate and extent of rapid inactivation increase with acetylcholine concentration,
indicating that acetylcholine binds to its self-inhibition site with apparent k0n = 103 M-'s' and kff c 40 s'-. This slow
k., suggests either hindered access to the inhibitory allosteric site or that a fast binding step is followed by a slower
conformational change leading to channel inhibition. Overall, our data suggest that acetylcholine binds preferentially to
its inhibitory site when the receptor is in the open-channel conformation and that fast desensitization can occur from all
muliple-liganded states.
INTRODUCTION
Depolarization of the motor endplate by acetylcholine
(ACh)' is mediated by a five-subunit protein complex, the
nicotinic acetylcholine receptor (AChR), which contains
binding sites for ACh and a cation selective transmem-
brane channel. In addition to stimulating AChR channel
opening, ACh inactivates channel function by three dif-
ferent mechanisms. Over increasing ACh concentration
ranges, these inactivation processes are termed slow desen-
sitization (seconds to minute time scale), fast desensitiza-
tion (milliseconds to seconds), and self inhibition (for
'Abbreviations used in this paper: ACh, acetylcholine; AChR, acetylcho-
line receptor; a-BTX, alpha-bungarotoxin; CCh, carbamylcholine; Dns-
C6-Chol, dansyl-C6-choline [1-(5-dimethylamino naphthalene) sulphon-
amido] n-hexanoic acid b-(N-trimethylammonium bromide) ethyl ester);
SubCh, suberyldicholine.
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reviews see Changeux et al., 1984 and Udgaonkar and
Hess, 1986). Slow and fast desensitization are thought to
be triggered by agonist binding to receptor sites (Katz and
Thesleff, 195'7; but see Dunn and Raftery, 1982), whereas
self inhibition is thought to occur by either a channel
blocking mechanism (Sine and Steinbach, 1984) or an
allosteric site mechanism (Pasquale et al., 1983; Takeyasu
et al., 1986).
In vitro studies of both ligand binding and rapid tracer
ion flux techniques in AChR-rich membrane vesicles from
electroplaque tissue of Torpedo species have provided
estimates of slow and fast desensitization rates. Slow
desensitization, which can be monitored in Torpedo AChR
with manual ion flux assays (Walker et al., 1981; Walker
et al., 1982) or binding experiments (Boyd and Cohen,
1980a; Neubig et al., 1982), has a maximum rate in the
presence of ACh or carbamylcholine (CCh), of -0.1 s-1
(Boyd and Cohen, 1980a; Walker et al., 1981; Hess et al.,
1982). Maximum rates for fast desensitization determined
from rapid quenched-flow ion flux measurements range
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from 1.5 s-' in native Torpedo vesicles (Hess et al., 1982;
Takeyasu et al., 1986) to 5.3 s-1 in reconstituted vesicles
(Walker et al., 1982).
In this paper, we present studies on the kinetics of the
third way in which ACh can inactivate channel function:
self inhibition. To resolve this phase of inhibition we found
it advantageous to pay strict attention to two factors.
First, desensitization rates derived from studies using
native Torpedo AChR-rich vesicles may be affected by
their small internal volumes and high surface AChR
densities (Neubig and Cohen, 1980; Forman et al., 1987).
If there are more AChR molecules than are required to
complete 86Rb+ exchange before it can be experimentally
terminated, the vesicles can be said to possess "spare
receptors" (Furchgott and Bursztyn, 1967). A theoretical
analysis of quenched-flow inactivation studies shows that
in the presence of spare receptors, the initial rate of
decrease of the integrated flux response would be lower.
than the true inactivation rate (see Appendix).
Second, the time resolution of quenched-flow studies
was improved to 86Rb+ flux periods of 3 ms and agonist
preincubation periods of 8 ms. ACh-induced inactivation
kinetics were then investigated in both channel activating
and self-inhibiting ranges. ACh, rather than CCh, was
chosen for this study because it is the natural ligand for
AChR and because concentration-response studies have
shown that ACh-induced activation and self inhibition




Purification of AChR from freshly killed Torpedo nobiliana (Biofish
Associates, Georgetown, MA) and determinations of concentration and
purity we performed as described previously (Forman et al., 1987).
Aliquots of receptor-rich membrane were suspended in Torpedo physio-
logical saline (TPS; 250 mM NaCl, 5 mM KCI, 2 mM MgCl2, 3 mM
CaC12, 5 mM pO42-, 0.02% NaN3; pH 7.0), frozen in liquid nitrogen, and
thawed up to 48 h before use. Vesicles were incubated for 20 min with 0.1
mM diisopropylfluorophosphate (DFP) to inhibit acetylcholinesterase
activity before flux assays.
Alpha-Bungarotoxin
a-BTX was repurified by ion exchange chromatography on CM-52
cellulose (Whatman, Maidstone, Kent, UK). Partial blockade of AChR
function in vesicle membranes was achieved by overnight incubation at
40C with desired stoichiometric amounts of a-BTX. For most quenched-
flow studies, 50-60% of [3H]-ACh sites were blocked.
Rapid Mixing Apparatus
Our apparatus is similar to that described by Cash and Hess (1981),
incorporating pneumatically driven syringes connected to both solution
reservoirs and a flexible flow system through three-way valves. Ball-type
mixing chambers (Berger et al., 1968) were supplied by Research
Instruments & Manufacturing Co., San Diego, CA. Actuation of pneu-
matic drives was controlled by a microcomputer (Apple II+, Cupertino,
CA) through a custom-built interface. Pneumatic drive movements
(coupled to a sliding variable resistor) were monitored by the computer
through a 12-bit analog-to-digital converter.
Estimation of Initial Flux Rates
All flux studies were performed at 40C. 86Rb+ efflux from native Torpedo
vesicles was measured with a rapid (3-4 ms) quenched-flow assay and the
percentage of nonleak counts (FA) calculated.
CPM(Ag) - CPM(leak)
F CPM(total) - CPM(leak) 1. (la)
Determination of CPM(leak) and CPM(total) have been previously
described (Forman et al., 1987). Estimated initial '6Rb+ efflux rates (kf)
from single time-point data were calculated as first order approxima-
tions.
k -In [1 - (FA T/F¢)]
T
(lb)
where T is the "6Rb+ efflux period, determined as described below, and Feq
is the measured flux after a long exposure to the maximum activating
ACh concentration (usually lO s with 1 mM ACh).
Determination of Inactivation Rates
Flow systems for assaying "6Rb+ influx after either short or long
inactivations in the presence ofACh are shown in Fig. 1. For inactivation
times (t) between 8 and 30 ms, a continuous double-mix quenched-flow
system was used (Fig. 1 A). 1 vol of vesicles (syringe V) was sequentially
mixed with (at Ml) 1 vol of desensitizing ACh solution (syringe A), (at
M2) 1 vol of flux solution containing ACh and 100 uCi/ml 86Rb+ (syringe
M+); and (at M3) I vol of 200 mM procaine (syringe Q). Variable
A
B
FIGURE 1 Schematic of quenched-flow experimental configurations.
(A) Double-mix quenched-flow experiment. Syringe V contains AChR-
rich vesicles; syringe A contains 2 x desensitizing ACh concentration (a);
syringe M+ contains both ACh and 86Rb+; and syringe Q contains 200
mM procaine "quench." (B) Pulsed quenched-flow experiment. Syringes
are labeled as above, except syringes T, which contain TPS.
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preincubation times (t) and influx periods (T) were achieved by altering
the lengths of DI and D2, respectively. Passage times through delay tubes
were calculated from linear least squares fitted slopes of drive tracings,
the known total volume slowing through each section of tubing and the
known delay tube volumes. Calculated passage times were within 2 ms of
calibration times estimated from base hydrolysis of o-NPA in the
apparatus (Neubig and Cohen, 1980).
For inactivation times >70 ms, pulsed quenched-flow (Fig. 1 B) was
performed essentially as described by Aoshima et al. (1981). Actuation of
the first pneumatic ram drove vesicles (syringe V) and desensitizing
solution (syringe A) through mixer MI into an aging tube. After an
inactivation delay (t), a second pneumatic ram flushed TPS (syringes T)
into the aging tube, displacing the vesicle/agonist solution, which was
rapidly mixed at M2 with flux solution (86Rb+ and ACh; syringe M+) and
then, at M3 with 200mM procaine (syringe Q). The rates of movement of
the two pneumatic rams were carefully matched by adjusting the driving
pressures so that all vesicles resided in the aging tube for the same amount
of time. Influx time (T) was varied by changing the length of Dl.
A portion of the quenched vesicle solution was collected by using a
sample-and-flush valve with a 175 ;d sample loop attached to the outflow
of M3. The sample-loop contents were flushed onto a small cation
exchange column (Dowex-50Wx8, 100-200 mesh, 1 ml bed volume) with
220 mM sucrose. Vesicles and entrapped 86Rb+ were eluted with another
aliquot of sucrose solution, mixed with scintillation cocktail, and counted.
Passive "6Rb+ leak into vesicles was measured either in the absence of
agonist or in the presence of 50 mM procaine. Leak corrected FA values
were calculated with Eq. la.
Nicotinic AChR channel activity in inactivation studies was deter-
mined from the amount of 86Rb+ which entered sealed vesicles and
expressed as FAUT (see Table I). Superscript variables represent ACh
concentration (a) and time (t) during desensitization, whereas subscript
variables represent conditions during 'Rb+ flux measurement. When the
desensitizing ACh was in the channel activating range (i.e., <1 mM),
AChR activity was measured with a 1 mM ACh influx assay. When ACh
concentrations above 1 mM (i.e., self-inhibiting range) were used for
desensitization, the receptor activity was measured in the presence of the
desensitizing ACh concentration. AChR activity before inactivation
(FA.T) was measured by the same technique used to measure the response
after inactivation, except that no ACh was used before 86Rb+ exposure
(i.e., syringe A contained TPS).
Flux responses were normalized to a maximum control response, F,m°M,T
determined with each series of experiments. Normalized data from
experiments in different time ranges could be combined for analysis. We




FA Integrated flux response in presence of ACh concentra-
tion A.
F.q Flux response corresponding to full equilibration of
"Rb+ across AChR-containing vesicle membranes.
FA0T Integrated flux response (time = T) without preincu-
bation (same as FA).
FA'T Integrated flux response after preincubation period t in
the presence of ACh concentration a.
kf 86Rb+ flux rate constant.
kd Fast desensitization rate constant.
kr Rapid inactivation rate constant.
KA ACh concentration eliciting FA(max)/2 response.
KB ACh concentration causing 50% self inhibition.
KD ACh concentration causing desensitization rate
kd(max)/2.
described by
FAaT = xFA Xexp(-kd x t), (2)
where kd is the desensitization rate. We plotted ln[FAT/F,'jm°.T] vs.
inactivation time (t) and calculated a linear least squares line using points
with t > 0. The slope of the fitted line was taken as kd.
Chemicals
Diisopropylfluorophosphate (DFP) was from Aldrich Chemical Co.,
Milwaukee, WI. Alpha-bungarotoxin was from Miami Serpentarium,
Miami, FL. Acetylcholine chloride, procaine hydrochloride, and buffer
reagents were from Sigma Chemical Co., St. Louis, MO. Radiochemi-
cals: [3H]-ACh was from New England Nuclear, Boston, MA, or
Amersham Corp., Arlington Heights, IL. Specific activities were deter-
mined by isotope dilution assays (Neubig and Cohen, 1979). 86RbCl was
from New England Nuclear.
RESULTS
Model analysis of quenched-flow data (Appendix) shows
that experimental conditions for accurate determination of
inactivation kinetics are achieved when a small fraction of
86Rb+ exchange (<0.35 x F¢q) is allowed when measuring
FA,T. Two experimental parameters can be modified to
establish these conditions: the 86Rb+ flux period (T) and
the rate of 86Rb+ exchange across vesicle membranes (kf).
Using maximum activating ACh conditions (1 mM ACh),
unmodified Torpedo AChR vesicles exchanged 0.72 x F.*4(F. represents maximum 86Rb+ exchange) in 5 ms. As
predicted by the model, the apparent desensitization rate
(kd) determined from plots of In [Fa4't] vs. inactivation time
(t) varies, depending on the points used for linear least
squares analysis. When 50% of the ACh channel activation
sites on these vesicles are blocked with a-BTX, the 5-ms
flux response drops to 0.31 x Feq and kd is independent of
the data points chosen for analysis.
ACh Concentration-Dependence of kd
Concentration-response curves in a-BTX treated Torpedo
vesicles for a variety of nicotinic agonists including ACh,
CCh, and suberyldicholine are bell-shaped, displaying both
agonist-dependent channel activation and self-inhibition at
high agonist concentrations (Forman et al., 1987). The
concentration-response curves are well described by a
biphasic logistic function:
FA =FA(max) x [[]Al +k [AI') I (3)
where FA is the 86Rb+ flux response, KA is the 50%
activating agonist concentration, N1 is the Hill coefficient
for activation, KB is the concentration causing 50% self
inhibition, and N2 is the Hill coefficient for self inhibition.
For ACh, significant channel activation is observed at
concentrations above 10 ,uM, increasing to a maximum
response plateau between 1 and 10 mM. Self inhibition is
observed above 10 mM ACh.
The time-courses of inactivation with ACh concentra-
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tions in both the activating and self-inhibiting ranges were
first studied with the pulsed quenched-flow technique (Fig.
2). In particular, we investigated whether inactivation was
strictly monoexponential. This was tested by comparing
the measured ln [Fo?,°T] with the y-axis intercept (t = 0)
from linear least squares regression of data for t > 0. If
these two values were the same within one standard error,
we considered inactivation to be monoexponential in the
time range studied.
With no ACh present during the inactivation pulse, no
time-dependent loss of flux activity is observed. Preincuba-
tion at the lowest ACh concentration tested (10 ,uM)
for >20 s or at higher ACh concentrations for <10 s
reduces 86Rb+ influx into vesicles to the passive leak level
(FA'/T= 0). When the desensitizing ACh is <1 mM, the
fitted y-intercepts are not significantly different from
ln [F%OMTI. Desensitization rate constants (kd), deter-
500
0
0 0.2 0.4 0.6 0.8 1.0
Preincubation time, t (s)
FIGURE 2 Inactivation kinetics under varying ACh desensitization con-
ditions. Vesicles were pretreated with a-BTX to block 60% of [3H]-ACh
sites. Flux responses (FAT) were measured with a pulsed quenched-flow
assay, as described in text and under Methods. Data for inactivation times
up to 1 s are shown. Full t range for 0, 10, and 32 gM ACh are not shown
for clarity (two additional points to 20 s, three additional points to 20 s,
and three additional points to 4 s, respectively). Calculated flux times (T)
for most points were from 3.0 to 3.5 ms. In each experimental series, a
control flux response with 1 mM ACh (F°m°MAT) was measured and used to
normalize data from different runs. Some flux responses were measured
at T > 3 ms (up to 13 ms) when activity after inactivation was low. These
responses were normalized by measuring at least one point in the
experimental set both at 3 ms and at the longer flux time. Data points
represent averages of at least three experiments. Plotted lines represent
linear least squares fits to data at t> 0 (solid for a < 1 mM Ach and
dashed for a > 1 mM ACh). Fitted values are as follows:
Preinc. ACh (a) In [FA- /FImM T] kd
mined from slopes of the fitted lines increase from 0.16 s-l
at 10 ,M ACh to 6.3 s-1 at 1 mM ACh. In inactivation
studies using 15, 50, and 100 mM ACh, y-intercepts of the
fitted lines (see table in legend) are lower than measured
In [FA T]S; FA/F0 ratios are 0.95 + 003 082 ±
0.03, and 0.68 ± 0.05, respectively. Slopes of these lines are
all close to the slope observed with 1 mM ACh.
Apparent kds for all ACh concentrations were also
derived from nonlinear least squares fits of flux data to Eq.
2 and are close to the slopes of the fitted lines in Fig. 2.
Fitted kds are plotted against ACh concentration in Fig. 3
(open squares). They show a sigmoidal dependence on
ACh and were fitted to the following logistic function by
nonlinear least squares.
kd = kd (max) x [AND
[AIND + KND)' (4)
KD is the ACh concentration causing a desensitization rate
of kd(max)/2 and ND is the Hill coefficient for ACh-
dependent desensitization. The data in Fig. 3 are fitted by
kd(max) = 6.6 ± 0.2 s-', KD = 102 ± 16 ,uM, and ND =
1.6 ± 0.3. Two other receptor preparations (not shown)
were characterized by kd(max) values of 8.0 ± 0.3 s-'and
6.9 ± 0.5 s-'.
For comparison to the kd vs. ACh curve, we also plotted
initial 86Rb+ efflux rates (kfs estimated using Eq. lb), vs.
ACh over the activating ACh range (Fig. 3, solid circles).
The kf vs. ACh curve closely parallels the kd vs. ACh
curve. Nonlinear least squares fitting to a logistic function
(Eq. 3, with kf instead of FA and KB = oo), gives kA(max) =










0 (0) 0.03 ± 0.06 1.03 ± 0.06 0.01 ± 0.03
10MM (0) -0.04 ± 0.02 0.96 ± 0.02 0.16 ± 0.02
32,uM (x) 0.05 ± 0.04 1.05 ± 0.04 0.94 ± 0.08
100 JAM (0) -0.06 ± 0.05 0.94 ± 0.05 3.2 ± 0.2
320MuM (+) -0.02 ± 0.04 0.98 ± 0.04 5.6 ± 0.2
1 mM (A) -0.05 ± 0.05 0.95 ± 0.05 6.3 ± 0.3
15 mM (-) -0.08 ± 0.04 0.92 ± 0.04 5.9 ± 0.4
50 mM (A) -0.69 ± 0.08 0.50 ± 0.04 6.1 ± 0.2
100mM (0) -1.09 ± 0.23 0.34 ± 0.08 6.6 ± 0.5
FIGURE 3 ACh concentration-response curves for flux rate and desensi-
tization rate. Initial efflux rates (kfs from Eq. lb in text; 0) were
estimated from averaged (N 2 3; vertical bars indicate 1 SD) flux
measurements in a single batch of a-BTX-treated vesicles (60% block).
The dashed line represents a nonlinear least squares fit to data using Eq. 3
with kf substituted for FA and KB = X-. Fitted parameters are kf(max) =
94 ± 8 s-5, KA = 77 ± 18 IM, and N, = 1.7 ± 0.2. Desensitization rates
(kds; solid *) were calculated from data in Fig. 2 using nonlinear least
squares fits to Eq. 2. The solid line represents a nonlinear least squares fit
to data using Eq. 4 in text. Fitted values are; kd(max) = 6.6 ± 0.2 s-',
KD= 102± 16MM,andND= 1.6 ±0.3.
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Rapid Inactivation at High ACh
Pulsed quenched-flow results show that extrapolated y-
intercepts are lower than measured ln [F?A?T] values with
15, 50, and 100 mM ACh (Fig. 2), indicating the presence
of an early (within 75 ms) inactivation of AChR. This
rapid inactivation phase at 50 and 100 mM ACh ("rapid"
indicating faster than "fast" desensitization) was further
investigated with a continuous double-mix quenched-flow
assay, which enabled measurements of inactivation effects
between 8 and 30 ms (Fig. 4 B). For a control, we also
performed double-mix quenched-flow studies using 1 mM
ACh. With 1 mM ACh, 15% inactivation is observed after
a 24-ms preincubation, indicating an inactivation rate of
6.8 s-'. At 50 mM ACh, flux dropped from 80% of control
(FO%M,T) at t = 0 to 38% of control in 30 ms, whereas 100
mM ACh caused a drop from 68% to 25% of control in
under 25 ms. To obtain estimates of rapid inactivation
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FIGURE 4 Rapid inactivation at 50 and 100 mM ACh. (A) Vesicles
were pretreated with a-BTX to block 60% of [3H]-ACh sites. Flux
responses (FA'j!) after preincubation periods < 30 ms were measured by
double-mix quenched-flow and combined with normalized data points
from Fig. 2. Calculated flux times (T) were between 3.0 and 3.3 ms. Data
was normalized to F°jA",T, as described for Fig. 2. Data points represent
averages of at least three experiments. Line through 1 mM ACh data
represents a linear least squares fit. Curves through 50 and 100 mM ACh
data points represent nonlinear least squares fits to Eq. 5. Fitted
parameters are: 1 mM ACh (El): intercept = 0.02 ± 0.05 (1.02 x FIO;OM,T),
slope -6.5 x 0.2 s-'. 50mM ACh (*): I, = 0.37 + 0.04, k, = 84.5 ± 18
s_', Id= 0.44 0.04, kd 5.3 ± 0.7 s-'.100mMACh (@): I,= 0.38+
0.03, kr = 155 + 27 s, Id = 0.30 ± 0.02, kd = 5.9 ± 0.8 s-'. (B) The first
40 ms of Fig. 4 A is shown on a larger scale.
experiments were combined (Fig. 4 A) and fitted to a
double exponential function.
FA,/FImM,T = I, x exp (-kr x t) + Id x exp (-kd X t), (5)
where I, and Id are the fractions of rapid inactivation and
fast desensitization, respectively, and kr and kd are the
exponential rate constants. Rapid inactivation rates from
fits to Eq. 5 (kr = 85 ± 18 s-' and 155 ± 27 s-' at 50 and
100 mM ACh) are 10- to 20-fold higher than kds from Fig.
2, while the kds derived from biphasic analysis are near the
earlier values. I, values for both biphasic curves are about
the same, but because FA0 is lower at 100 mM ACh than
at 50 mM, the extent of rapid inactivation is relatively
higher at 100 mM ACh. Fig. 4 B shows the first 40 ms of
the fitted inactivation curves, illustrating that back-extra-
polations of the rapid phases reach the control flux level at
t = -4.5 ms with 50 mM, and at t = -3.7 ms with 100
mM ACh.
DISCUSSION
Effects of Spare Receptors
By combining the use of very short tracer flux assay
periods with a-BTX-treated Torpedo vesicles, we elimi-
nated a number of problems encountered when studying
inactivation kinetics in native Torpedo vesicles. In the
experiment described in the Appendix to this paper (Fig.
5), the initial 86Rb+ flux rate (kf) before a-BTX treatment
was too high to accurately measure with a 5 ms flux assay.
The inactivation rate (kd) determined from the resulting
nonlinear ln (FA) vs. t plot depends on the set of points
chosen for linear analysis (2.9 s-1 initially, increasing to 4.9
s-' after 75 ms). After irreversible blockade of half of the
ACh sites, the flux rate decreases, the plotted data are
linear, and the apparent kd increases (6.7 s-i).
Spare receptors in Torpedo vesicles have previously
been cited as a problem in determination of inactivation
rates (Hess et al., 1982; Heidmann et al., 1983). The
strategy adopted by Hess et al. (1982) was to use the
agonist-induced inactivation process to reduce 86Rb+ flux
rates to "measurable" levels. At their most potent agonist
concentration (10 mM CCh), inactivation for at least 200
ms was required before flux levels decreased in a time-
dependent manner. Initial flux rates were estimated by
back extrapolation (inactivation was assumed to be mono-
exponential). Heidmann et al. (1983) attempted to over-
come the spare receptor problem by using the fluorescent
agonist, Dns-C6-Chol, which elicits much lower initial flux
rates than ACh. The low flux is probably caused, as with
other partial agonists (Adams and Sakmann, 1978), by
Dns-C6-Chol self-inhibition occurring in the same concen-
tration range as activation (i.e., KB=- KA in Eq. 3; Forman
et al., 1987). The analytical method used by Heidmann et
al. fitted flux data to a function in which both kf and kd
were variables, providing accurately fitted kds only when
they were comparable to kf.
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In the present study, measured responses (FAs) were
proportional to 86Rb+ flux rates, enabling us to directly
measure the pre-desensitized response (F?,?T) and effects of
very short inactivation periods. Using a-BTX to reduce kf
has been criticized (Hess et al., 1982) because toxin
binding may affect the interaction of agonists with AChR.
However, Sine and Taylor (1980) showed that a-BTX,
which binds without preference to two ACh sites on the
AChR monomer, prevents agonist-mediated channel open-
ing in BC3H1 cells when bound to either one or both sites.
Thus, flux signal is contributed only by unmodified
AChRs, which are present at a relative concentration of
(1 X)2, where X is the fraction of toxin-bound ACh
sites. Concentration-response curves for AChR activation
by CCh both without (Walker et al., 1981) and with
(Neubig and Cohen, 1980; Forman et al., 1987) partial
a-BTX blockade are similar. In the experiment described
in our Appendix, the estimated kf was reduced by -70%
after 50% a-BTX blockade, consistent with Sine and
Taylor's conclusions.
ACh Concentration-Dependence of kd
Over the entire range of desensitizing ACh concentrations
studied (10,uM to 100 mM), In [FAt] vs. t data at 75 ms <
t were well fitted by straight lines (Fig. 2). In addition,
y-intercepts of fitted lines with ACh between 10 M and 1
mM, differed by <5% from measured ln [FA0 ] values. We
conclude that desensitization in the presence of <1 mM
ACh is monophasic at times <1 s. Others have shown that
a slow phase of desensitization (0.1 s-1 and below) is
observable in Torpedo vesicles (Walker et al., 1981; Hess
et al., 1982; Walker et al., 1982) and at the amphibian
neuromuscular junction (Sakmann et al., 1980; Feltz and
Trautmann, 1982; Chestnut, 1983) after fast desensitiza-
tion. This slow phase was not observed in our study,
because fast desensitization with >1010M ACh eliminated
essentially all cation channel activity. However, our results
do not exclude the presence of slow desensitization,
because the flux times (T) used were not long enough to
enable detection of very low flux rates remaining after
rapid desensitization.
Results summarized in Fig. 3 show that the ACh
concentrations at the half-maximal fast desensitization
rate (KD in Eq. 4) and the half-maximal 86Rb+ flux rate
(KA) are not significantly different and that the Hill
coefficients for desensitization and flux are close (ND = 1.6
compared with N, = 1.7). This strongly suggests that both
fast desensitization and cation channel opening are trig-
gered by ACh binding to two activation sites. In Figs. 2 and
3, kds estimated from pulsed quenched-flow data at 15, 50,
and 100 mM ACh are close to the kd at 1 mM ACh. This
plateau in kd at agonist concentrations above those that
saturate ACh activation sites was previously observed at up
to 10 mM ACh in Torpedo (Takeyasu et al., 1986;
Huganir et al., 1986) and with both ACh and suberyldi-
choline in Electrophorus vesicles (Pasquale et al., 1983;
Takeyasu et al., 1983).
Maximum kds in this study are three- to fourfold higher
than those from previous reports of quenched-flow experi-
ments in native Torpedo vesicles at 0-40C (Walker et al.,
1981; Hess et al., 1982; Takeyasu et al., 1986). Although
most previous measurements were made in Torpedo cali-
fornica, which may display different inactivation kinetics,
the lower kds derived in other studies might be attributed to
the presence of spare receptors. Indeed, our kd(max) values
are comparable to rates derived from experiments using
Torpedo californica receptor reconstituted into vesicles
(5.3 s-1; Walker et al., 1982) and Electrophorus vesicles
(7 s-1; Cash et al., 1981; Hess et al., 1982). Like a-BTX
blocked vesicles, these systems are also characterized by
low 86Rb+ flux rates.
Mechanism of Fast Desensitization
Katz and Thesleff (1957) originally proposed that desensi-
tization is triggered by agonist binding to channel activa-
tion sites, but the nature of the ACh-bound state(s) from
which desensitization proceeds has remained uncertain.
Slow desensitization is known to proceed at ACh concen-
trations where negligible channel opening occurs and the
Hill coefficient for slow rates is 1.0 (Neubig et al., 1982).
Consequently, it has been suggested that slow desensitiza-
tion occurs from a singly-liganded AChR state (i.e., only
one activating site bound to agonist). Consistent with this
scheme, an irreversibly bound agonist analogue, bromoace-
tylcholine, also blocks agonist binding to desensitized
receptors (Damle and Karlin, 1978; Wolosin et al., 1980).
Previous quenched-flow results in both Electrophorus
(Aoshima et al., 1981; Cash and Hess, 1981) and Torpedo
vesicles (Hess et al., 1982; Heidmann et al., 1983;
Takeyasu et al., 1986; Huganir et al., 1986) are consistent
with a model where fast desensitization occurs from a
doubly-liganded "pre-open" AChR state in rapid equilib-
rium with the open channel state (Hess et al., 1983).
Results that argue against this model are rather conflict-
ing. In reconstituted AChR, Walker et al. (1982) found
KD> KA and ND close to 1.0, while ligand binding studies
using [3H]-ACh (Boyd and Cohen, 1980b) indicate KD <
KA. Our results support a mechanism where fast desensiti-
zation occurs from all doubly-liganded AChR states (to be
discussed further).
Rapid Inactivation
With 50 and 100 mM ACh, pulsed quenched-flow experi-
ments revealed an AChR inactivation process occurring
before fast desensitization, which we have termed rapid
inactivation. A continuous double-mix quenched-flow
experiment resolved the time-course of rapid inactivation.
ACh-induced inactivation on this time scale has been
previously reported in studies of frequency-dependent
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nerve stimulation at the frog neuromuscular junction
(Magleby and Pallotta, 1981).
Rapid inactivation is almost certainly the same process
as the self inhibition by agonists observed in integrated flux
experiments. Both the rate and extent of rapid inactivation
increase in parallel with self inhibition observed in inte-
grated flux assays (Forman et al., 1987). Rapid inactiva-
tion cannot be the result of higher rates of fast desensitiza-
tion at very high ACh, as suggested by Walker et al.
(1982), because rapid inactivation rates (kr) are 10- to
20-fold higher than kd(max), which shows a clear plateau
between 1 and 15 mM ACh. Additional inactivation
phases with rates matching kd(max) are observed after
rapid inactivation is complete with both 50 and 100 mM
ACh.
Back-extrapolations of the rapid inactivation phases in
curves from Fig. 4 B intersect the FO'OM value at about
t -4 ms, close to the flux assay times calculated from
tracings of pneumatic ram movements plus mixing times
for ball-type cells used in our apparatus (estimated at -0.3
ms; Berger et al., 1968). Thus, the FOA0T values observed
with 50 and 100 mM ACh may be attributed to rapid
inactivation during the flux assay. To test this possibility,
we calculated integrated flux reponses in the presence of
both rapid inactivation and fast desensitization with the
following equation, analogous to the equation derived by
Neubig and Cohen (1980) for desensitization alone.
FA,T = Fq X [I - exp (-kf [1 - exp (-krT)1
+
Id [1- exp (-kdT)I })]. (6)kd
where parameters are defined as in Eq. 5 (also see Table I)
and Ir + Id = 1. For calculations of integrated flux in the
presence of 1, 50, and 100 mM ACh, kf was set at the
experimental kK(max) (94 s-'). Other parameters were set
at the values derived from analysis of Fig. 4 B, except Irh
which was set at 1 - Id
For a flux time (T) of 3.5 ms, Eq. 6 predicts F5OmM/FI mM
- 0.93 (7% inhibition) and Floo.mM/FlmM = 0.85 (15%
inhibition). Measured F?AO.5. values in Fig. 4 show signifi-
cantly more self inhibition than these calculations, indicat-
ing that some portion of the self-inhibition process may be
occurring at rates beyond the time resolution of our
rapid-mixing apparatus. Simulations with Eq. 6 predict
observed FO5, values for 50 and 100 mM ACh when krs
are 340 s-' and 480 s-1, respectively.
Mechanisms of Self Inhibition
Both allosteric and channel blocking mechanisms for self
inhibition have been proposed (see Pasquale et al., 1983).
Both mechanisms assume a bimolecular interaction
between ACh and a self-inhibition site:
kB1
B + Jl . RB
koff
(7a)
In this model, B represents the inhibitory ligand (ACh),
and I? represents those receptor states possessing a self-
inhibition site (e.g., unbound receptor, receptor with one
ACh activating site occupied, receptor with both activating
sites occupied, receptors with open cation channels, and
desensitized receptor). The observed rate of rapid inactiva-
tion is
=krff + (B x k,,). (7b)
Although it is not known which AChR states are inhibited,
self-inhibiting ACh concentrations are much higher than
the dissociation constant for activation sites (KA in Eq. 3),
so that the distribution of AChR states before binding the
inhibitory site is invariant with ACh concentration (note
that when KB is close to KA, as with partial agonists, this is
not the case; Forman et al., 1987). The dissociation
constant for binding to the self-inhibition site is:
KB= [B] X [R] = kOff[BIB] kon (7c)
Because rapid inactivation is essentially complete (i.e.,
at equilibrium) before fast desensitization, the ratio of
noninhibited to inhibited receptors in scheme 7a can be
estimated from analysis of biphasic inactivation curves as
[S]]/[B] = Id/II. Using Id values from analysis of Fig. 4
and setting I, = 1 - Id, in Eq. 7c, we derive k1. = 950
M-'s-' and k0ff = 37 s-' (KB = 39 mM) for data at 50 mM
ACh, and kon = 1,080 M-ls-1 and koff = 47 s-' (KB= 43
mM) at 100 mM ACh, two independent estimates that do
not differ significantly from each other. KBs derived from
this analysis are in excellent agreement with values for
ACh self inhibition reported from both single channel
studies in BC3H1 cells (50 mM; Sine and Steinbach,
1984) and flux studies in Electrophorus vesicles (50 mM;
Takeyasu et al., 1986).
Our results show that self inhibition may occur only
after channel activation, suggesting a mechanism in which
agonists bind selectively to open channels. This mechanism
predicts that initial 86Rb+ flux rates are not reduced unless
channel inhibition occurs much faster than 86Rb+ flux. Our
data also require that the blocked state may directly
desensitize without reopening, since a sequential block
model where only unblocked channels desensitize predicts
incorrectly that the rate of desensitization will decrease at
self-inhibiting ACh concentrations. A mechanism in which
all multiply-liganded receptor states (including the open
channel and blocked states) desensitize at the same rate
(Pasquale et al., 1983) is most compatible with available
data. Desensitization from the inhibitor-bound state is also
supported by evidence that inhibitors reduce integrated
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flux over long times (Neher, 1983), as observed with both
suberyldicholine and (-)-nicotine in Torpedo vesicles
using 10 s 86Rb+ flux (Forman et al., 1987). In addition,
channel blockers remain "trapped" within AChR channels
after ACh dissociates (Gurney and Rang, 1984; Neely and
Lingle, 1986).
Support for selective binding to open channels comes
from single-channel traces in the presence of self-inhibiting
agonist doses (Sine and Steinbach, 1984; Ogden and
Colquhoun, 1985), which show rapid closing events within
channel openings, similar to those seen with local anesthe-
tics (Neher and Steinbach, 1978). The self-inhibitory
potencies of agonists are voltage dependent (Sine and
Steinbach, 1984; Takeyasu et al., 1986; Ogden and Colqu-
houn, 1985), as are the potencies of local anesthetics,
indicating a site partway across the membrane voltage
gradient (Adams, 1977). Recent studies in Torpedo (Heid-
mann and Changeux, 1986) also show that [3H]-chlor-
promazine, a noncompetitive inhibitor, selectively photola-
bels open channels, but does not bind to either resting or
desensitized AChR. Our low ko, could be attributed to a
diffusion barrier in this model. One possibility is that the
blocking site is on the cytoplasmic side of the membrane.
Indeed, there is evidence that agonists pass through the
AChR channel (Case et al., 1977; Sine and Steinbach,
1984) and that the site of local anesthetic inhibition on
AChR may be intracellular (Gage et al., 1983).
An alternative mechanism where agonists bind to an
allosteric self-inhibitory site accessible on all receptor
states with equal affinity has been proposed (Pasquale et
al., 1983; Shiono et al., 1984; Takeyasu et al., 1986). The
difficulty with this model is that self inhibition occurs
simultaneously with activation, reducing initial ion flux
rates. Because our kon rates for self-inhibitor binding are
four to five orders of magnitude slower than diffusion-
limited bimolecular association rates for ACh binding to
the activation sites on AChR (106 to 108 M-'s-'; Boyd and
Cohen, 1980b; Lester and Nerbonne, 1982), the allosteric
model must be modified so that either binding of ACh to
the allosteric site is slow or a rate limiting conformational
change leading to channel inhibition occurs after a diffu-
sion-limited binding step (Neher and Steinbach, 1978).
At present, there is no data that conclusively supports
either the allosteric site model or the channel block model
for self inhibition by agonists. These two models might be
distinguished by determining whether rapid inactivation
rates depend linearly (block model with rate-limiting
bimolecular association step) or hyperbolically (saturable
allosteric site) on ACh concentration. In this study, the
range of rapid inactivation rates (and therefore ACh
concentrations) was limited by the quenched-flow method.
Unfortunately, recently introduced spectrophotometric
stopped-flow methods (Karpen et al., 1983) and rapid
perfusion electrophysiological techniques (Brett et al.,
1986) do not give significantly better time resolution than
quenched-flow. A more sensitive test of the two mecha-
nisms may be provided by noncompetitive antagonists,
which inhibit AChR function in a manner similar to
agonists. A noncompetitive inhibitor that acts at the self-
inhibition site for agonists could be used to determine
directly whether or not the site is accessible before channel
activation.
APPENDIX
Model Analysis of Spare Receptor Effects
We initially develop a simple model of our quenched-flow influx experi-
ment for measurement of agonist-induced inactivation rates. As described
in Methods, vesicles are first exposed to the desired concentration ofACh
(a) for a period (t) of inactivation. The inactivated vesicle solution is then
mixed with a solution containing ACh (at concentration A) and 86Rb+ for
a second short time, T, before the flux reaction is quenched with
flux-inhibiting drugs. In this analysis, we assume that 86Rb+ influx into
vesicles follows simple two-compartment kinetics where the internal
vesicle volume is negligibly small in comparison with the total reaction
volume. In the absence of desensitization, the flux signal, FA (see Table I
for definitions of variables), increases with T.
FAT = F,q x [1- exp (-ko x T)], (Al)
where kf is the initial rate constant for 86Rb+ influx into vesicles in the
presence of ACh at concentration A, and F,, is the 86Rb+ content of
ACh-activated vesicles after full equilibration across membranes (see
Methods). We also assume that the flux rate decreases exponentially
during desensitization.
k'= k' x exp (-kd xt), (A2)
where kd is the true rate of desensitization in the presence of the
experimental agonist concentration, a. T is short enough so that little or
no desensitization occurs during 86Rb+ influx. With these conditions, the
flux signal is
FAJT=F xqx1l-exp[-k'x Txexp(-kdx t)]}. (A3)
Following the methods used elsewhere in this paper, we plot ln[FA,,-
(normalized to F,q) vs. inactivation time (expressed in units of k-').
Fig. 5 A illustrates that the shape of the relationship between FArT and t
depends on the dimensionless parameter k' x T, which also determines
the response observed before desensitization (FA',° / F,q; Eq. Al). At k' x
T values of 0.1 and 0.3 the curves shown in Fig. 5 A are approximately
linear with the ideal slope of 1.0, indicating the true desensitization rate,
while their intercepts on the y-axis indicate that flux signal will be only
9.5 and 26% of F,, respectively. At higher k' x Tvalues, the initial slope
of the curves decrease, but approach 1.0 at longer and longer times. For
example, with k' x T = 5.0, our model predicts that F°- /F,q decreases by
only 16% after an e-fold decrease in kf (at kd X t = 1.0).
Experimental Effects of Spare Receptors
Fig. 5 B shows data from pulsed quenched-flow inactivation experiments
using two aliquots from a single batch of AChR vesicles. One aliquot
(solid 0) was incubated overnight with a 50% stoichiometric amount of
a-BTX, whereas the other (solid El) was incubated overnight with the
same volume of TPS. Inactivation and 5 ms 86Rb+ flux were in the
presence of 1 mM ACh and flux measurements were normalized to F qs
for comparison to Fig. 5 A. Fq values (Table I, Methods), measured with
I mM ACh and 10 s manual influx assays were 80 ± 3% for the
unblocked aliquot and 74 ± 5% for the a-BTX-treated aliquot.
Blockade with a-BTX reduced the preincubation response, F10M,SID,s by
53% whereas estimated k' (Eq. Ib) was reduced by 71% (from 250 to 73
s-'). Given that k' x T parameters characterizing the blocked and
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FIGURE 5 Apparent desensitization kinetics under varying flux assay
conditions. (A) Curves represent desensitization kinetics predicted by Eq.
A3. The abscissa is a time axis which has been normalized to the intrinsic
desensitization rate, kd, and is therefore dimensionless. Values overlaid on
curves are kf x T conditions for the flux assay, where kf is the initial
vesicle flux rate. (B) Desensitization kinetics at 1 mM ACh before and
after removal of spare receptors. Flux responses after preincubation with
ACh (in pulse mode) were measured with a 5-ms quenched-flux assay
and normalized to F,q, which was measured with a manual 10 s influx
assay. Points represent averages of at least three runs. FAO- values were
measured by preincubating with TPS instead ofACh solution. Solid lines
through data represent linear least squares fits to data points with t > 0.
Untreated vesicles (U); fitted slope = -4.9 ± 0.4 s-', fitted intercept =
-0.07 ± 0.10, equivalent to 0.93 (± 0.09) x F,q. FA.,,, = 0.72 (± 0.06) x
Faq, significantly different from the fitted intercept (P < 0.05). The
dashed line through untreated vesicle data was calculated for 0 s t s 0.2
s; fitted slope = -2.9 ± 0.2 s ', fitted intercept = 0.31 ± 0.03, equivalent
to 0.73 (± 0.02) x F = q. Vesicles with 50% [3H]-ACh sites blocked by
a-BTX (0); fitted slope - - 6.7 ± 0.4 s-', fitted intercept = -1.2 ± 0.1,
equivalent to 0.30 (± 0.03) x Feq; FAOOS,5,, = 0.31 (xO.03) x Feq.
unblocked vesicles are 0.37 and 1.25, respectively, the data in Fig. 5 B
closely resemble the predictions of the analytical model (Fig. 5 A). Linear
least squares analysis of ln[FA.'>] vs. t data (i.e., omitting the t = 0
points) are shown in Fig. 5 B (solid lines). The fitted line for data from
unblocked vesicles has a slope of -4.9 s-' and y-intercept corresponding
to 0.93 x Faq. This back-extrapolated t = 0 response is significantly higher
than the measured Fj?°M,T (P < 0.05). The apparent initial rate of fast
desensitization for the unblocked vesicles was derived from a linear least
squares fit to data points at t < 0.4 s (dashed line, slope = 2.9 s-'). This is
40% lower than the slope of the solid line, illustrating that apparent
desensitization rates can vary markedly when k1 x T is high. In contrast,
data from 50% blocked vesicles gives a slope of -6.7 s-' and a y-intercept
of 0.30 x F,q, close to the measured FIOOM,T
The above analysis and experimental data clearly show that interpreta-
tion of inactivation kinetics is improved when k1 x T is low, because the
apparent desensitization rate varies at high k1 x T values. In the present
study, our methods were sensitive to changes of 0.03 x F,q, and we used
a-BTX blockade levels that resulted in FAOO /FO9 s 0.35 (14 x T s 0.43).
Empirically, we found that kds determined from a single AChR batch
differed by <10%.
Our model also suggests two important caveats when interpreting
quenched-flow inactivation data. Firstly, the presence of multiple rapid
inactivation processes, such as those described in the present study, may
be masked when k' x T is high, because F1,Tjat low t values reflect a lower
apparent inactivation rate than the true rate. This is reflected in the
concave downward curves in Fig. 5 A. As demonstrated in our pulsed
quenched-flow studies at low k' x T, inactivation processes occurring
more rapidly than the shortest experimental inactivation period (t), but
slower than the flux assay (T) were revealed by back-extrapolated
y-intercepts from ln[FA!T] vs. t data (t > 0) that were lower than the
experimental ln[FA°.]. This observation correctly suggested a concave
upward inactivation curve.
Secondly, for accurate analysis of agonist-dependent changes in kd, it is
best to use standard conditions for flux activity assays. If the test agonist
concentration is varied (e.g., when the concentration during 86Rb+ influx
[A] is matched to the desensitizing concentration [a]), a systematic
underestimation of kd that increases with agonist concentration may be
introduced. This error will cause the apparent slope (Hill coefficient) of
kd vs. agonist plots to be underestimated.
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